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Abstract
Background: The treatment of periacetabular malignant bone tumours is challenging. Many methods of
reconstruction after internal hemipelvectomy have been reported and each method has its own limitations.
The aim of this study was to evaluate the oncological and functional outcomes of pasteurized autograft
reconstruction after resection of periacetabular malignant bone tumours.
Methods: Ten patients (six male, four female) with periacetabular malignant tumours, who underwent
resection and reconstruction with pasteurized autograft, were retrospectively reviewed. The patients’ average
age at diagnosis was 40 years (range 13–65 years). There were five patients with chondrosarcoma, three with
osteosarcoma, one with Ewing’s sarcoma, and one with solitary metastatic thyroid carcinoma.
Results: At the last follow-up, seven patients were alive (six with no evidence of the primary disease and one
with lung metastasis for 5 months). The three other patients died of metastasis of the primary disease with a
mean survival time of 12 (range 8–17) months postoperatively. The mean follow-up time for all patients was
45 (range 8–87) months. Local recurrence rate was 10%. The mean time of bone union was 12 (range 6–21)
months after the operation. The mean Musculoskeletal Tumor Society score for all living patients at the last
follow-up was 70.5% (range 43.3–86.7%).
Conclusions: Reconstruction with pasteurized autograft is a feasible method for treating periacetabular
malignant bone tumours, with satisfactory oncological and functional outcomes and a relatively low incidence
of complications.
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Background
With the development in neoadjuvant and adjuvant treat-
ments, surgical techniques, and imaging techniques, the
prognosis for malignant bone tumours has considerably
improved. However, the treatment of pelvic malignant
bone tumours is still challenging because of the anatom-
ical complexity of the pelvis and the difficulty in achieving
wide surgical margins and reconstructing large bone and
soft tissue defects after tumour resection, especially in the
periacetabular region [1, 2].
The methods for the reconstruction of the periacetabu-
lar region include (1) arthrodesis [3, 4]; (2) pseudarthrosis
[3, 5, 6]; (3) cement reinforced by rods or pins [7, 8];
(4) hemipelvic prosthesis replacement [9–17]; (5) allo-
graft implantation [18–20]; and (6) autograft implant-
ation [8, 18, 21–23].
For autografting, the replacement of the extracorpore-
ally irradiated [21, 22] or autoclaved [8, 18] tumour-
bearing bone has been reported by many authors to
be a feasible method for reconstruction after pelvic
malignant bone tumour resection. To our knowledge,
only a few studies have reported reconstruction with
pasteurized autograft for periacetabular malignant
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The purpose of this retrospective study was to evaluate
the oncological and functional outcomes of pasteurized




Between February 2007 and August 2012, 10 patients
with periacetabular malignant bone tumour underwent
tumour resection and replacement with pasteurized
autograft in our hospital. Patient characteristics are
shown in Table 1. There were six male and four female
subjects. The patients’ average age at diagnosis was 40
(range 13–65) years. After preoperative staging, which
included plain radiography, magnetic resonance imaging
(MRI) of the pelvis, and computed tomography (CT) of
the chest, needle biopsy was performed for each patient.
There were five patients with chondrosarcoma, three
with osteosarcoma, one with Ewing’s sarcoma, and one
with solitary metastatic thyroid carcinoma. Seven pri-
mary malignant bone tumours were staged as IIB and
two were staged as IB according to the Enneking staging
system. The solitary metastatic thyroid carcinoma was
contained within the innominate bone. In all patients,
the pelvic bone structure was not evidently destroyed by
the tumour.
All patients with osteosarcoma and the patient with
Ewing’s sarcoma received neoadjuvant and adjuvant
chemotherapy with a high dose of methotrexate, doxo-
rubicin, cisplatin, and isofosfamide. The patient with
Ewing’s sarcoma also received adjuvant radiotherapy
after local recurrence and lung metastasis. The patient
with solitary metastatic thyroid carcinoma received
iodine-131 therapy postoperatively.
There were six cases of type I + II resection, two cases
of type II + III resection, and two cases of type I + II + III
resection according to the Enneking system.
Surgical technique
A senior surgeon (Qing Zhang) performed all the opera-
tions. The operations were performed with the patients
in a lateral position maintained by bags and rolls, which
allowed semi-supine and semi-prone positions. Whole
or part ilioinguinal and Smith-Petersen incisions were
used. The external iliac vessels and the femoral and sci-
atic nerve were carefully dissected and protected. If the
anterior superior iliac spine was not invaded by the
tumour, the anterior superior iliac spine was osteoto-
mized and retracted inferiorly with the sartorius muscle.
If the tumour did not invade the hip joint, the joint cap-
sule was excised. Femoral neck osteotomy was per-
formed with an oscillating saw after the dislocation of
the hip. If the hip joint was invaded by the tumour, fem-
oral osteotomy was performed outside the hip joint
capsule. The planned levels of pelvic osteotomy were
identified. The osteotomies were performed with a Gigli
saw. Subsequently, the tumour was completely removed
with a layer of normal tissue and the needle biopsy track.
If the hip joint was invaded by the tumour, the pelvis
and femoral head were removed en bloc. If the tumour
did not invade the hip joint, the pelvis and femoral head
were removed separately.
The bone was pasteurized as described in our previous
reports [25, 26]. Briefly, soft tissue and gross tumour
were thoroughly cleared from the specimen. The speci-
men was then treated in preheated saline at 65 °C for
30 min (YCX-2 Thermostatic Water Bath, Zhengrong
Yiqi, China). The acetabulum was reamed extracorpore-
ally according to its original direction until all the cartil-
age had been removed. Several holes were drilled
through the subchondral bone plate of the ilium, is-
chium, and pubis. The acetabular component was fixed
with bone cement in the correct direction (Fig. 1). Areas
of defect caused by tumour involvement were filled with
bone cement at the same time. The protruding part of
the iliac wing which could cause abnormal soft tissue
tension was resected. The autograft was returned to its
original anatomic site and fixed with plates and screws.
Usually, tow reconstruction plates were used, one placed
along the arcuate line and pubic ramus and another
placed along the posterior side of the ilium and ischial
tuberosity. If the anterior superior iliac spine with the
sartorius muscle was osteotomized, it was fixed to the
autograft with a screw. A standard cemented or cement-
less femoral component implantation was performed.
Thereafter, the muscles were reattached as far as pos-
sible to their original position through the drilled holes
in the bone to cover the bone and prosthesis with the
remaining muscles. The wound was closed with 1 or 2
suction drainages.
Postoperative treatment
Postoperatively, patients were kept in bed for 2–4 weeks,
with the affected extremity in a 15° abduction, 15° hip
and knee flexion, and rotary neutral position with an
orthosis to prevent dislocation of the hip joint, followed
by non-weight-bearing movement. Progressive weight
bearing was allowed at postoperative 6 weeks with tow
crutches. The drainage tube was removed when the out-
put was <50 ml per day, usually 1–2 weeks after the op-
eration. Intravenous antibiotic was administrated until
the drainage tube was removed. Patients started mech-
anical anti-embolism exercise immediately after the
operation. No chemical anti-embolism drug was used.
Follow-up
All patients were followed up clinically and radiologically
(radiograph of the pelvis and chest) every month for
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6 months, every 3 months for 2 years, and every
6 months thereafter. A CT scan of the chest was per-
formed every 3 months in the first year and every
6 months subsequently. If there was a suspicion of local
recurrence or metastasis, a CT scan was immediately
performed. Functional outcome was evaluated using the
Musculoskeletal Tumor Society (MSTS) lower extremity
score [27] at the final clinical follow-up.
Results
All patients were followed up either until October
2015 or death. At the final follow-up, seven patients
were alive: six with no evidence of the primary dis-
ease and one with lung metastasis for 5 months.
Three patients (two with osteosarcoma and one with
Ewing’s sarcoma) died of primary disease metastasis
with a mean survival time of 12 (range 8–17) months
postoperatively. The mean follow-up time for all pa-
tients was 45 (range 8–87) months, and the mean
follow-up time for survived patients was 58 (range
38–87) months.
Resection margins were wide in seven patients, marginal
in two patients, and contaminated in one patient. In the
current study, if the plane of dissection was 2–3 cm away
from the tumour or outside the compartments in all di-
rections, we considered it a wide margin. If the plane did
not achieve adequate distance from the tumour in any dir-
ection because important vessels or nerves were too close
to the tumour, we considered it a marginal margin. If the
margin was contaminated by tumour content during the
operation, we considered it a contaminated margin. One
patient with contaminated margin had local recurrence in
soft tissue but not in the bone at 6 months postopera-
tively, who refused further treatment because lung metas-
tasis was also discovered during this period.
When a bridging callus appeared between the host
bone and pasteurized autograft in an anteroposterior
radiograph of the pelvis, we considered that bone
union was achieved. Bone union was achieved in
eight patients. The mean time of bone union was 12
(range 6–21) months after the operation (Fig. 2). One
patient’s autograft was removed because of deep in-
fection before bone union was achieved. Another pa-
tient died at 8 months postoperatively because of
lung metastasis before bone union was achieved. Bone
resorption was found in one patient at the inferior
ramus of pubis (Fig. 1). It began at 2 months after
the operation and did not progress a year later. No
stress fracture or autograft collapse was observed in
the current study.
Two patients had wound necrosis; one was treated
with change of dressing alone and the other with a
superficial infection received debridement. Deep infec-
tion occurred in one patient at 4 months postoperatively
during the period of adjuvant chemotherapy with isofos-
famide. The deep infection was controlled after
Fig. 1 Patient 7 was a 48-year-old female with chondrosarcoma. a Preoperative AP radiograph. b Preoperative MRI. c Pasteurized autograft ready
to be returned. d AP radiograph 54 months postoperatively. Bone resorption was observed at the inferior ramus of the pubis
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removing the autograft bone and prosthesis, and no fur-
ther reconstruction was performed.
A plate which fixed the synchondroses pubis was
broken in one patient at postoperative 12 months, but
the patient felt no pain at the site and limb function was
unaffected. There was no aseptic loosening of prosthesis
in the current study.
Dislocation occurred in one patient at 8 days after the
operation because of inadequate nursing care. After
closed reduction and bed rest for 3 weeks with orthosis,
no redislocation occurred. No neurologic complication
was observed in the current study.
The mean MSTS score for all survived patients at the
final follow-up was 70.5% (range 43.3–86.7%). The mean
MSTS score for patients with autograft and prosthesis in
situ was 75.0% (range 60.0–86.6%). The MSTS score for
the patient whose autograft and prosthesis were re-
moved because of deep infection was 43.3%.
Discussion
Resection of malignant pelvic bone tumours with a safe
margin is difficult. However, internal hemipelvectomy
which saves the limb may theoretically achieve the same
surgical margin as external hemipelvectomy in most
cases [19, 28]. The oncologic outcomes were not signifi-
cantly different between internal and external hemipel-
vectomy [1]. The resection of periacetabular bone
malignant tumours disrupts force transfers between the
trunk and the affected lower limb and affects hip joint
function [10]. For reconstruction of the pelvic ring and
restoration of hip joint function, various methods are
used in clinical practice. Each of these methods has its
own limitations.
To obtain adequate hip joint function, the pelvis
should be reconstructed as originally as possible to
maintain the position of the hip centre of rotation,
femur and acetabulum offset, and limb length, to keep
an optimal gluteal moment arm [22]. Reconstruction
with combined hemipelvic prosthesis could place the
acetabulum in the correct position and direction [13];
however, it was difficult to fix the prosthesis in the cor-
rect position and direction during the operation, because
of the geometrical complexity of the pelvis and large de-
fects in the bone and soft tissue. Computer-aided
custom-made hemipelvic prosthesis could help solve this
problem [10]. Yet, accurate resection is needed to ensure
the correct sitting of the prosthesis; otherwise, the devi-
ation of the acetabular position and direction will occur;
thus, the use of a navigation system during resection is
recommended [11].
From our point of view, replacement of the treated
tumour-bearing bone is relatively easier and an eco-
nomic way to restore the original position and direction
of the acetabulum. Pasteurization is an alternative
method to tumour-bearing bone treatment for recon-
struction after the resection of a malignant bone tumour
[24–26, 29–31]. In the current study, we used pasteur-
ized autografts to reconstruct the pelvis after periacetab-
ular malignant bone tumour resection; the mean MSTS
score for patients with autograft and prosthesis in situ
was 75.0% (range 60–86.6%) which was comparable to
other reports (Table 2). Using an autograft providing
Fig. 2 Patient 9 was a 13-year-old male with osteosarcoma. a Preoperative AP radiograph. b Preoperative MRI. c Bone union was achieved at
6 months postoperatively
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acceptable anatomical reconstruction is one of the
reasons good hip function was achieved in this study.
Apart from the reconstruction of the structure of the
pelvis and hip joint, reconstruction of the muscles is
also one of the important factors for a good func-
tional outcome [2, 16, 19]. We reattached remain
muscles as far as possible to their original position
through the drilled holes in the pasteurized bone.
Pasteurization of the autograft is sufficient for killing
all the tumour cells in the massive bone [29, 30, 32].
Local recurrence rates with pasteurized autograft use
were not significantly different compared with prosthesis
[26] and allograft [31]. In the current study, one patient
(10%) had local recurrence in soft tissue but not in the
pasteurized autograft.
There was no effective compartmental barrier for the
pelvic tumour [3]. The anatomical structure of the pel-
vis, the intrapelvic visceral organs, and the neurovascular
structures are complex. Although MRI provides an ex-
cellent image of the tumour extension, it is difficult to
translate this image into a three-dimensional structure
during the operation to achieve a safety resection margin
[1, 13]. The achieved surgical margin and tumour stage
are significant prognostic factors which affect onco-
logical outcome [1]. The overall survival rate in the
current study was 70% and the local recurrence rate
was 10% which were comparable to other reports
(Table 2); however, our mean follow-up duration was
only 45 months.
In addition to the primary tumours, the metastatic
lesion of the pelvis was one of the indications for en
bloc tumour resection and reconstruction in patients
with periacetabular malignant tumour. However, the
procedure should be limited to patients with solitary
metastatic lesion from tumours which have good sur-
vival expectancy, such as thyroid, prostate, or breast
carcinoma [15, 17, 33]. Nevertheless, some authors do
not recommend reconstructing with allograft and
recycled tumour-bearing bone for metastatic lesions
because of the long rehabilitation period [15]. In this
study, one patient with solitary metastatic thyroid car-
cinoma achieved good functional result (MSTS 86.7%)
and was still alive without disease for 87 months at
the final follow-up. Although we only presented one
patient in the current study, we believe that a solitary
metastatic lesion should not be a contraindication for
reconstruction with pasteurized autograft for periace-
tabular malignant tumour because of the relatively
long survival expectancy in selected patients.
Reconstruction with a pasteurized autograft is a well-
established method in certain countries, particularly in
Asia and Africa. It is a simple, easily accessible, and
economical alternative to the usual reconstruction mo-
dalities with comparable oncological and functional out-
comes, in addition to its social and religious acceptance
in these countries [23–26, 34, 35]. However, the usage of
replacement autograft is limited by the quality of the
autograft. The structure of the bone should not be vis-
ibly destroyed by the tumour [18, 22, 23]. And using
pasteurized autograft would cause the lack of material
for the overall histologic assessment of the chemother-
apy effect. Moreover, a variety of complications associ-
ated with pasteurized autografts have been described,
including delayed or nonunion of the junction, graft
fracture, collapse, bone absorption, pseudarthrosis, and
mechanical implant failure, infection [23–26].
Compared with autoclaving, pasteurization of auto-
graft does not only eliminate malignant cells but also
preserves the osteo-inductive activity of the human bone
morphogenetic protein [29, 30, 32]. In the current study,
if the anterior superior iliac spine was not invaded by
tumour, we osteotomized it with the sartorius muscle
and fixed it to the pasteurized autograft with a screw.
This may have improved the blood supply to the
Table 2 Comparison with other studies















Current study 10 Pasteurized
autograft
45 (8–87) 70 10 10 10 70.5




87 (13–142) 78 14 21 36 71.6




56 (12–164) 60 20 0 13 76.6




51 (4–185) 50 17 17 6 77.0
Delloye et al. [20]
(2007)
24 Allograft 41 (1–137) 33a 29 13 8 73.0




53 (24–102) 64 20 15 9 57.2
MSTS Musculoskeletal Tumor Society score
aThree deaths were not related to the tumour
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pasteurized autograft for better new bone ingrowth. The
mean time of bone union in the current study was
12 months (range 6–21) months postoperatively. It was
much shorter than we reported previously; 18 months
for the humerus [26] and 19 months for the tibia [25].
There was no nonunion in the current study, while the
nonunion rate was 25.0% for the humerus [26] and
54.5% for the tibia [25] in our previous studies. This may
have been due to a better blood supply in the pelvis than
in the humerus and tibia. The nonunion rate of recon-
struction using autograft and allograft after pelvic
tumour resection ranged from 0 to 36.8% in other stud-
ies [18–23].
There was no case of stress fracture in the current
study. Stress fracture rate of the autograft and allograft
ranged from 0 to 21.4% in other reports [18–23].
Langlais et al. reported one patient with acetabular fossa
stress fracture 2 years after allograft reconstruction. Dur-
ing the revision operation, poorly vascularized bone was
found at the fracture site [19]. One reason for the stress
fracture occurrence is that dead bone with no self-repair
ability was not replaced by the ingrowth of the new
bone. The pasteurized autograft could be one of reasons
for the absence of stress fracture in the current study be-
cause it may have preserved the osteo-inductive activity
of the human bone morphogenetic protein. In another
study in which pasteurized autografts were used for the
reconstruction of periacetabular malignant tumour, the
fracture rate was 14% (2/14). The authors assumed that
graft disruption caused by the tumour was the reason
for the fractures [23]. In the current study, the structures
of all autografts were not evidently destroyed by tumour.
We also considered this as one of the reasons for the
absence of fractures in our study.
Bone absorption is one of the usual complications of
pasteurization. Kim et al. reported bone absorption rate
was 18% (2/11) in their study, an acetabulum fracture
after bone absorption of the pasteurized acetabulum was
occurred in one of these patients [24]. In the current
study, bone absorption was observed in one patient
(10%) at the inferior ramus of pubis 2 months postoper-
atively, but it did not progress a year later.
There was a breakage of plate which fixed the syn-
chondroses pubis in the current study at 12 months after
the operation, but there was no impact on limb function.
Nonunion is a significant cause of implant failure. How-
ever, there was no nonunion in this patient and we
thought that micro motion at the synchondroses pubis
was the cause of the breakage. Strong scar healing
contributed to the stabilization of the pelvic ring and
prevented the patient from experiencing pain and dys-
function. Because there was no impact on limb function,
and no pain at the site of breakage, no further treatment
was conducted for the breakage of the plate.
Infection is one of the most common and serious
complications of reconstruction after resection of pel-
vic tumours. Deep infection rates range from 0 to
25% and may cause implant removal, amputation, and
even death [9, 12–17]. In the current study, one pa-
tient (10%) had deep infection 4 months postopera-
tively, during the period of adjuvant chemotherapy.
The deep infection was controlled after the autograft
bone and prosthesis were removed. The other patient
had a superficial infection which was treated with de-
bridement. Extensive resection, large wound cavity,
hematoma, adjuvant chemotherapy, the long duration
of surgery, large amounts of blood loss, and the lack
of soft tissue coverage are considered reasons for the
high infection rate [17, 36–39]. We resected the pro-
truding part of the iliac wing to reduce the tension of
the soft tissue and provide better soft tissue coverage
as postulated by Langlais et al. [19] and Guo et al.
[13]. Muscle flap is recommended for better soft tis-
sue coverage if necessary [14]. Sufficient drainage
helps reduce the infection rate by preventing
hematoma [17]. We kept the drainage tube in situ,
until the output was <50 ml per day. Using
antibiotic-laden cement may also help in reducing the
infection rate [40].
Dislocation is another common complication in re-
construction after periacetabular tumour resection.
Dislocation rates range from 0 to 35.7% and patients
with redislocation may need revision [14–17, 23]. One
patient (10%) experienced dislocation in this study.
Fisher et al. pointed out that the main reason for dis-
location was extensive resection of the muscle around
the hip joint and recommended ‘buttercup’ exercises
for all their patients to prevent dislocation [40]. The
faulty positioning of the acetabular cup is also one of
the reasons for dislocation. It is difficult to adjust the
acetabular cup fixation point when using most hemi-
pelvic prosthesis during operation [10]. Reducing the
risk of dislocation might be one of the advantages of
reconstruction with pasteurized autograft, because
using an autograft restores the original position and
direction of the acetabulum.
Limitations
There were several limitations in the current study. First,
the number of patients was small because of the low
morbidity of this disease and limited indication for this
method. Second, it was a retrospective study without a
control group mainly because of the same reason above;
thus, we compared our findings with other similar re-
ports. Third, the current study was only a short-term
follow-up study; nevertheless, a summary of short-term
results is still valuable with regard to early complications
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and functional outcomes for patients with malignant
disease.
Conclusions
Pasteurized autograft reconstruction is a feasible method
for treating periacetabular malignant bone tumours with
satisfactory oncological and functional outcome and a
relatively low incidence of complications. It has several
advantages: (1) provision of adequate anatomical recon-
struction for achieve good function, (2) relative ease of
fixation during operation, (3) convenient technique for
treating autograft, (4) avoidance of disease transmission
or immunological reactions, and (5) economic efficiency.
However, to avoid graft failure, the structure of the
tumour-bearing bone should not be obviously destroyed
by tumour, and this may limit the usage of the pasteur-
ized autograft reconstruction to selected patients.
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